Published in Acta Neuropathol Commun on March 16, 2016
Enhanced susceptibility of triple transgenic Alzheimer's disease (3xTg-AD) mice to acute infection. J Neuroinflammation (2017) 0.77
Reexamining Chronic Toxoplasma gondii Infection: Surprising Activity for a "Dormant" Parasite. Curr Clin Microbiol Rep (2016) 0.75
Toxoplasma Co-infection Prevents Th2 Differentiation and Leads to a Helminth-Specific Th1 Response. Front Cell Infect Microbiol (2017) 0.75
TREM2 in Neurodegenerative Diseases. Mol Neurodegener (2017) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
Toxoplasmosis. Lancet (2004) 13.96
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (2010) 12.15
TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35
Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16
Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science (2010) 8.04
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci (2006) 6.52
Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron (2006) 6.38
Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med (2007) 5.87
Microglia in neurodegenerative disease. Nat Rev Neurol (2010) 5.83
Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell (2010) 4.45
Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci (2006) 4.30
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci (2011) 4.21
Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature (1995) 4.18
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol (2001) 4.12
Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron (2003) 4.11
Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity (2008) 4.07
Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci (2008) 3.90
Ageing and infection. Lancet Infect Dis (2002) 3.79
Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med (2009) 3.68
Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci (2002) 2.97
A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem (2002) 2.85
Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med (2012) 2.56
The dementias. Lancet (2002) 2.42
Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J Neurosci (2011) 2.31
Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci (2015) 2.25
Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J Neurosci (2004) 2.24
PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease. Nat Med (2016) 2.22
TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell (2015) 2.15
PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice. J Neurosci (2012) 2.12
Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis (2007) 2.08
A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal (2012) 2.03
Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 2.01
Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis (2005) 1.88
Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A (2009) 1.83
Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci (2009) 1.80
Microglia and neurodegeneration: the role of systemic inflammation. Glia (2012) 1.73
Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur J Immunol (1988) 1.73
Chitinase dependent control of protozoan cyst burden in the brain. PLoS Pathog (2012) 1.68
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'. Nat Neurosci (2015) 1.60
Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience (2007) 1.59
Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis (2013) 1.54
Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci (2005) 1.54
Proteolytic degradation of amyloid β-protein. Cold Spring Harb Perspect Med (2012) 1.46
Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation (2008) 1.41
Migrating monocytes recruited to the spleen play an important role in control of blood stage malaria. Blood (2009) 1.40
Immune response and immunopathology during toxoplasmosis. Semin Immunopathol (2012) 1.38
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation (2012) 1.36
Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. J Pathol (2012) 1.36
Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med (2013) 1.30
Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. J Neurosci (2000) 1.27
Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J Immunol (2000) 1.26
Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J Neurosci (2012) 1.25
Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer's disease. J Exp Med (2015) 1.21
Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer's disease-like mice. J Exp Med (2015) 1.20
The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J (2013) 1.16
Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. Mol Psychiatry (2006) 1.16
Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice. J Neurosci (2011) 1.14
Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell Rep (2013) 1.13
Assessing the contribution of inflammation in models of Alzheimer's disease. Biochem Soc Trans (2011) 1.12
Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction. Neurobiol Aging (2014) 1.11
The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution. Front Mol Neurosci (2014) 1.10
Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice. J Clin Invest (2011) 1.10
Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord (2011) 1.10
Acquired infection with Toxoplasma gondii in adult mice results in sensorimotor deficits but normal cognitive behavior despite widespread brain pathology. Microbes Infect (2010) 1.09
Microglia actions in Alzheimer’s disease. Acta Neuropathol (2013) 1.09
Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med (2011) 1.08
Selecting a mouse model of Alzheimer's disease. Methods Mol Biol (2011) 1.08
Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by Toxoplasma gondii on host dopamine. Infect Immun (2014) 1.07
Mice infected with low-virulence strains of Toxoplasma gondii lose their innate aversion to cat urine, even after extensive parasite clearance. PLoS One (2013) 1.05
TREM2 in Alzheimer's disease. Mol Neurobiol (2013) 1.04
Toxoplasma gondii actively inhibits neuronal function in chronically infected mice. PLoS One (2012) 1.04
Review: systemic inflammation and Alzheimer's disease. Neuropathol Appl Neurobiol (2013) 1.03
Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse. Behav Brain Res (2012) 1.03
Reactive glia show increased immunoproteasome activity in Alzheimer's disease. Brain (2013) 0.99
Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect Immun (2003) 0.99
Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer's disease. J Neurosci (2015) 0.99
Neurocytopathic effects of beta-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease. Proc Natl Acad Sci U S A (1996) 0.98
Mitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasis. Acta Neuropathol (2012) 0.97
Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression? Neurosci Biobehav Rev (2009) 0.97
Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease. Int J Alzheimers Dis (2012) 0.96
Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. Mol Med (2012) 0.96
Toxoplasma gondii impairs memory in infected seniors. Brain Behav Immun (2013) 0.96
Reduced immunoproteasome formation and accumulation of immunoproteasomal precursors in the brains of lymphocytic choriomeningitis virus-infected mice. J Immunol (2010) 0.96
TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol (2015) 0.95
Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer's disease. PLoS One (2012) 0.95
Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Behav Brain Res (2011) 0.94
ABC transporters B1, C1 and G2 differentially regulate neuroregeneration in mice. PLoS One (2012) 0.94
Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer's-like disease progression. Nat Commun (2013) 0.93
Regulating amyloidogenesis through the natural triggering receptor expressed in myeloid/microglial cells 2 (TREM2). Front Cell Neurosci (2014) 0.92
Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease. J Alzheimers Dis (2015) 0.91
Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice. Neurobiol Aging (2013) 0.91
Toxoplasma gondii-induced neuronal alterations. Parasite Immunol (2015) 0.91
Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice. Curr Alzheimer Res (2013) 0.90
Systematic substrate identification indicates a central role for the metalloprotease ADAM10 in axon targeting and synapse function. Elife (2016) 0.83
Neuroplastin deletion in glutamatergic neurons impairs selective brain functions and calcium regulation: implication for cognitive deterioration. Sci Rep (2017) 0.75